1/79
Vocabulary flashcards covering amino acids, protein structure and folding, hemoglobin, lipids, enzyme kinetics, bioenergetics, metabolic pathways, and organic chemistry functional groups and mechanisms.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Zwitterion
The dipolar ionic form of an amino acid at physiological pH, carrying a positively charged amino group (−NH3+) and a negatively charged carboxyl group (−COO−).

Peptide Bond
A covalent, planar bond with partial double-bond character formed between the carboxyl group of one amino acid and the amino group of another, eliminating a molecule of water (H2O).
Primary Structure of Proteins
The specific linear sequence of amino acids in a polypeptide chain connected by peptide bonds, which determines all higher structural levels.

Secondary Structure of Proteins
Local, regular arrangements of the polypeptide backbone, primarily including α-helices and β-sheets, stabilized mainly by hydrogen bonds involving the backbone.
Tertiary Structure of Proteins
The complete three-dimensional shape of a single polypeptide chain, resulting from interactions between side chain −R groups such as hydrophobic interactions, hydrogen bonds, ionic bonds, van der Waals forces, and disulfide bonds.

Quaternary Structure of Proteins
The spatial arrangement and association of multiple distinct polypeptide subunits that assemble to form a single functional protein complex.
Denaturation
The disruption of a protein's normal secondary, tertiary, or quaternary three-dimensional structure without breaking its covalent peptide bonds.
Chaperone Proteins
Proteins (such as Hsp70 and Hsp90) that assist other proteins to fold correctly, maintain stability, prevent inappropriate aggregation, or refold after stress.
Chaperonins
Specialized multi-protein chaperone complexes (such as GroEL/GroES or Hsp60) that provide an enclosed, protected barrel-like environment favorable for protein folding.

Hemoglobin A (HbA)
An adult red blood cell protein composed of four polypeptide chains (α2β2) and four heme groups, capable of reversibly binding up to 4 O2 molecules.
Bohr Effect
The reduction in hemoglobin's affinity for oxygen caused by increased CO2 concentration and higher H+ concentration (lower pH), favoring oxygen unloading in metabolically active tissues.
Methemoglobin
An altered form of hemoglobin in which the heme iron is oxidized from the functional ferrous state (Fe2+) to the ferric state (Fe3+), impairing oxygen binding.
Carboxyhemoglobin
Hemoglobin bound to carbon monoxide (CO), which binds with higher affinity than oxygen, occupying binding sites and impairing oxygen delivery to tissues.
Fetal Hemoglobin (HbF)
The tetrameric fetal oxygen-transport protein with an α2γ2 subunit structure that exhibits a higher affinity for O2 than adult HbA due to weaker 2,3-BPG binding.

Myoglobin
A monomeric oxygen-binding protein found in skeletal and cardiac muscle consisting of 1 polypeptide chain and 1 heme group with a single Fe2+ ion, displaying a hyperbolic oxygen dissociation curve.
Cytochromes
Heme-containing electron-transfer proteins in which the iron alternates between Fe3+⇌Fe2+, crucial for the mitochondrial electron transport chain.
Glycoproteins
Proteins containing carbohydrate groups covalently attached to their polypeptide chains, classified as N-linked (attached to Asn) or O-linked (attached to Ser or Thr).

Saturated Fatty Acids
Fatty acids containing no carbon-carbon double bonds, allowing hydrocarbon chains to pack tightly, resulting in higher melting points and solid consistency at room temperature.

Triacylglycerols
Biological lipids composed of a glycerol backbone esterified to three fatty acids, serving as the body's primary hydrophobic, energy-dense long-term energy storage form in adipose tissue.

Phospholipids
Amphipathic membrane lipids typically composed of glycerol, two fatty acid tails, a phosphate group, and a polar head group, which spontaneously form lipid bilayers in aqueous environments.
Gangliosides
Complex glycolipids containing one or more sialic acid residues, abundant in neuronal membranes; deficient degradation leads to lysosomal storage disorders like Tay-Sachs disease.

Cholesterol
The principal animal sterol containing four fused hydrocarbon rings and a hydroxyl group, serving as a membrane fluidity regulator and precursor for steroid hormones, bile acids, and vitamin D.
Enzymes
Biological catalysts, primarily globular proteins, that increase the rate of biochemical reactions by lowering activation energy (Ea) without being consumed or altering overall ΔG.

Induced-Fit Model
The model of enzyme-substrate interaction where the binding of the substrate induces a conformational change in the enzyme's active site to optimize catalytic fit and chemical reaction.

Activation Energy (Ea)
The minimum initial energy barrier that reactant molecules must overcome for a chemical transformation to occur.
Exergonic Reactions
Thermodynamically favorable reactions characterized by a negative change in Gibbs free energy (ΔG<0) that release energy.
Endergonic Reactions
Thermodynamically non-spontaneous reactions characterized by a positive change in Gibbs free energy (ΔG>0) that require an input of free energy.
Adenosine Triphosphate (ATP)
The primary energy currency of the cell, composed of adenine, ribose, and three phosphate groups, which drives endergonic cellular processes upon hydrolysis.
Catabolism
Metabolic pathways that break down complex molecules into simpler compounds, releasing free energy conserved as ATP and reduced electron carriers (NADH, FADH2).
Anabolism
Biosynthetic metabolic pathways that construct complex cellular macromolecules from simpler precursors, requiring ATP and reducing power (NADPH).

Glycolysis
A 10-step cytosolic metabolic pathway that converts 1 molecule of glucose into 2 molecules of pyruvate, generating a net yield of 2 ATP and 2 NADH without requiring O2 directly.
Phosphofructokinase-1 (PFK-1)
The key committed, rate-limiting regulatory enzyme of glycolysis that phosphorylates fructose-6-phosphate to fructose-1,6-bisphosphate; inhibited by ATP/citrate and activated by AMP/ADP/F-2,6-BP.
Pyruvate Dehydrogenase Complex (PDH)
A multi-enzyme mitochondrial matrix complex that oxidizes pyruvate to acetyl-CoA, producing 1 NADH and 1 CO2 per pyruvate molecule.

Citric Acid Cycle (Krebs Cycle)
An 8-step amphibolic metabolic pathway in the mitochondrial matrix that oxidizes acetyl-CoA to CO2, producing 3 NADH, 1 FADH2, and 1 GTP/ATP per acetyl-CoA.

Electron Transport Chain (ETC)
A series of inner mitochondrial membrane protein complexes (I–IV) and mobile carriers (CoQ, Cyt c) that transfer electrons to oxygen, pumping protons to establish a gradient.
Chemiosmosis
The process wherein the electrochemical proton gradient across the inner mitochondrial membrane drives protons through ATP synthase to catalyze ADP + Pi→ATP.

Lactic Acid Fermentation
An anaerobic pathway in cytosol catalyzed by lactate dehydrogenase, reducing pyruvate to lactate to regenerate NAD+ so glycolysis can continue producing ATP.

Alcoholic Fermentation
An anaerobic two-step pathway in yeast converting pyruvate to acetaldehyde and then ethanol, releasing CO2 and regenerating NAD+.
Purine Salvage Pathway
A pathway that recycles free purine bases (hypoxanthine, guanine via HGPRT; adenine via APRT) into nucleotides, reducing de novo energy consumption.
Lesch-Nyhan Syndrome
An X-linked genetic disorder caused by severe HGPRT deficiency, leading to excessive de novo purine synthesis, hyperuricemia, gout, and severe neurological/behavioral symptoms.

Heme Synthesis
An 8-step pathway occurring partly in mitochondria and cytosol starting with glycine and succinyl-CoA; rate-limited by ALA synthase and finalized by ferrochelatase inserting Fe2+.
Porphyrias
A group of metabolic disorders caused by enzymatic defects in the heme biosynthesis pathway, leading to accumulation of toxic porphyrin precursors.
Competitive Inhibition
Enzyme inhibition where the inhibitor competes directly with substrate for active site binding, increasing Km while leaving Vmax unchanged.

Non-competitive Inhibition
Enzyme inhibition where the inhibitor binds an allosteric site regardless of substrate presence, decreasing Vmax while leaving Km unchanged.
Uncompetitive Inhibition
Enzyme inhibition where the inhibitor binds exclusively to the enzyme-substrate (ES) complex, reducing both Vmax and Km.
Zymogens
Inactive enzyme precursors (e.g., trypsinogen, pepsinogen) requiring selective proteolytic cleavage to become catalytically active.
Isoenzymes
Multiple structural forms of an enzyme that catalyze the same chemical reaction but differ in amino acid sequence, tissue distribution, and kinetic properties.
Reactive Oxygen Species (ROS)
Highly reactive oxygen derivatives (e.g., O2•− superoxide, H2O2, •OH) that cause cellular damage to DNA, proteins, and lipids if not neutralized by antioxidant enzymes.
Glycogenesis
The pathway converting excess glucose into glycogen for storage in liver and muscle, catalyzed key step by glycogen synthase under insulin stimulation.
Glycogenolysis
The enzymatic breakdown of glycogen to glucose-1-phosphate in response to glucagon (liver) or epinephrine (muscle), rate-limited by glycogen phosphorylase.
Gluconeogenesis
The de novo synthesis of glucose from non-carbohydrate precursors (lactate, glycerol, amino acids) occurring primarily in the liver during fasting.
Pentose Phosphate Pathway (PPP)
A cytosolic glucose pathway that generates NADPH for reductive biosynthesis/antioxidant defense and ribose-5-phosphate for nucleotide synthesis.
β−Oxidation
The mitochondrial catabolic pathway that sequentially breaks down fatty acyl-CoA molecules into acetyl-CoA, producing NADH and FADH2.
Ketone Bodies
Water-soluble fuel molecules (acetoacetate, β−hydroxybutyrate, acetone) produced by liver mitochondria from fatty-acid-derived acetyl-CoA during low carbohydrate availability.

Lipoproteins
Spherical lipid-protein complexes (Chylomicrons, VLDL, LDL, HDL) containing a hydrophobic core of TAGs/cholesteryl esters and an amphipathic coat for lipid transport in blood.
Transamination
The transfer of an α−amino group from an amino acid to an α−keto acid (typically α−ketoglutarate), catalyzed by aminotransferases requiring pyridoxal phosphate (PLP/Vitamin B6).
Urea Cycle
A hepatic pathway split between mitochondria and cytosol that converts toxic free ammonia (NH4+) into non-toxic urea for renal excretion.
Hydrocarbons
Organic compounds consisting entirely of carbon and hydrogen atoms, categorized into alkanes, alkenes, alkynes, and aromatic compounds.
Alkanes
Saturated hydrocarbons with general formula CnH2n+2 containing only sp3-hybridized carbon single bonds (σ bonds).
Alkenes
Unsaturated hydrocarbons with general formula CnH2n containing a carbon-carbon double bond composed of 1 σ bond and 1 π bond between sp2 carbons.
Alkynes
Unsaturated hydrocarbons with general formula CnH2n−2 containing a carbon-carbon triple bond composed of 1 σ bond and 2 π bonds between sp carbons.
Markovnikov's Rule
Regioselectivity rule stating that in electrophilic addition of HX to an unsymmetrical alkene, H adds to the carbon with more hydrogen atoms to yield the more stable carbocation intermediate.

Benzene
A cyclic planar aromatic hydrocarbon (C6H6) possessing a delocalized system of 6 π electrons across its ring.
Hückel's Rule
Rule stating that a planar, cyclic, continuously conjugated ring system is aromatic if it contains 4n+2 π electrons (where n is a non-negative integer).
Electrophilic Aromatic Substitution (EAS)
An organic reaction mechanism in which an electrophile replaces a hydrogen atom on an aromatic ring, passing through an arenium intermediate while preserving ring aromaticity.
Enantiomers
Stereoisomers that are non-superimposable mirror images of each other, having identical physical properties in achiral environments but opposite optical rotation.

Diastereomers
Stereoisomers that are not mirror images of one another and generally possess different physical and chemical properties.
SN2 Mechanism
Bimolecular nucleophilic substitution occurring in a single concerted step via backside attack, causing complete inversion of stereochemical configuration at methyl or primary carbons.
SN1 Mechanism
Unimolecular two-step nucleophilic substitution proceeding through a rate-limiting carbocation intermediate, favored by tertiary substrates.
E2 Elimination
Bimolecular concerted elimination requiring a strong base to abstract a β−hydrogen while the leaving group departs, forming a C=C double bond.
E1 Elimination
Unimolecular two-step elimination proceeding through a carbocation intermediate from which a base abstracts a β−hydrogen to yield an alkene.

Phenols
Aromatic compounds with a hydroxyl group directly bonded to a benzene ring (C6H5OH); substantially more acidic than alcohols due to resonance stabilization of the phenoxide ion.
Thiols
Sulfur analogues of alcohols (R−SH) containing a sulfhydryl group, capable of oxidation to form covalent disulfide bonds (R−S−S−R).
Nucleophilic Addition
The characteristic reaction of carbonyl compounds (aldehydes/ketones) where an electron-rich nucleophile attacks the electrophilic carbonyl carbon, breaking the C=O π bond.
Hemiacetals
Compounds formed by nucleophilic addition of an alcohol to an aldehyde, featuring a carbon bound to −OH, −OR′, −R, and −H.
Keto-Enol Tautomerism
A constitutional isomerism equilibrium between a carbonyl compound with an α−hydrogen (keto form) and an unsaturated alcohol (enol form).
Nucleophilic Acyl Substitution
The characteristic reaction of carboxylic acid derivatives (R−CO−LG) involving nucleophilic attack on the carbonyl carbon to form a tetrahedral intermediate followed by elimination of the leaving group.
Anomeric Carbon
The stereogenic carbon created during carbohydrate cyclization that was the electrophilic carbonyl carbon in the open-chain form.
Mutarotation
The change in specific optical rotation observed when α and β anomers interconvert via the open-chain form in aqueous solution until equilibrium is reached.
Reducing Sugars
Carbohydrates possessing a free hemiacetal or hemiketal anomeric carbon capable of opening to an aldehyde or ketone to act as a reducing agent.